1-9 of 9
Johanna Melo-Cardenas, B.Sc
Close
Sort by
Journal Articles

BMS-936564 (MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Apoptosis in an in Vitro Model of Stromal – Leukemia Cell Interaction for Chronic Lymphocytic Leukemia.

Manoj Kumar Kashyap, PhD, Deepak Kumar, PhD, Harrison Jones Jones, BS, Michael Y. Choi, MD, Johanna Melo-Cardenas, B.Sc, Michelle R. Kuhne, PhD, Peter Sabbatini, PhD, Lewis Cohen, MD, MS, Suresh Shelat, MD-PhD, Pina M Cardarelli, Ph.D., Thomas J. Kipps, MD, PhD, Januario E. Castro, M.D.
Journal: Blood
Blood (2012) 120 (21): 2887.
https://doi.org/10.1182/blood.V120.21.2887.2887
Published: 2012
Journal Articles

Heat Shock Protein 90 (Hsp90) Activity Status Is An Independent Prognostic Marker in Chronic Lymphocytic Leukemia (CLL) and Correlates with IgV H Mutational Status, ZAP-70 Expression and Time to First Treatment

Januario E. Castro, M.D., Juan S. Barajas-Gamboa, M.D., Julio A. Diaz-Perez, M.D., M.S., Lina M. Ariza-Serrano, M.D. (c), Johanna Melo-Cardenas, B.Sc, Mauricio Rodriguez, D.D.S., M.S., Mauricio Urquiza, Ph.D., Thomas J. Kipps, M.D., Ph.D
Journal: Blood
Blood (2011) 118 (21): 2544.
https://doi.org/10.1182/blood.V118.21.2544.2544
Published: 2011
Journal Articles

Ad-ISF35-Transduced Autologous Cells In Combination with Fludarabine, Cyclophosphamide, Rituximab (FCR) Induces Complete and Partial Responses In a Phase 1b Study for Patients with Fludarabine-Refractory and/or Del(17p)/p53-Defective Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, M.D., Lee Schwartzberg, MD, FACP, Javier Pinilla-Ibarz, MD, PhD, Johanna Melo-Cardenas, B.Sc, Juan S. Barajas-Gamboa, M.D., Mark J. Cantwell, PhD, Thomas J. Kipps, M.D., Ph.D
Journal: Blood
Blood (2011) 118 (21): 168.
https://doi.org/10.1182/blood.V118.21.168.168
Published: 2011
Journal Articles

Ad-ISF35 Intratumoral Administration Induces a Bystander Effect and Immune-Mediated Tumor Rejection with a Safe Vector Biodistribution and Toxicology Profile In a NHL Mouse Model.

Johanna Melo-Cardenas, B.Sc, Mauricio Urquiza, PhD, Robier Aguillon-Prada, M.D, Thomas J. Kipps, MD, PhD, Januario E Castro, M.D
Journal: Blood
Blood (2010) 116 (21): 1470.
https://doi.org/10.1182/blood.V116.21.1470.1470
Published: 2010
Journal Articles

Ad-ISF35- Transduced Autologous Cells Promote In Vitro and In Vivo Chemosensitization to FCR and Durable Complete Responses In Patients with Del(17p)/P53 Defective Chronic Lymphocytic Leukemia.

Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Mauricio Urquiza, PhD, Mark J. Cantwell, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1472.
https://doi.org/10.1182/blood.V116.21.1472.1472
Published: 2010
Journal Articles

Immune Gene Therapy for Patients with CLL Using Repeat Dose Intranodal Injection of Ad-ISF35, a Replication Incompetent Vector Expressing a Membrane-Stable CD40 Binding Protein.

Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Ramin Sean Pakbaz, M.D, Mauricio Urquiza, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1476.
https://doi.org/10.1182/blood.V116.21.1476.1476
Published: 2010
Journal Articles

Ofatumumab and High-Dose Methylprednisolone Is An Effective Salvage Treatment for Heavily Pretreated, Unfit or Refractory Patients with Chronic Lymphocytic Leukemia: Single Institution Experience

Januario E Castro, M.D, Juan Sebastian Barajas-Gamboa, M.D, Johanna Melo-Cardenas, B.Sc, Rosa N Paz, Cesar Bernal-Corzo, Amine Ale-Ali, Pharm., D., Danelle F. James, M.D, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4638.
https://doi.org/10.1182/blood.V116.21.4638.4638
Published: 2010
Journal Articles

Ad-ISF35-Transduced Autologous Cells Promote in Vitro and In Vivo Chemosensitization to FCR in Patients with Del(17p) / P53 Defective Chronic Lymphocytic Leukemia.

Januario E. Castro, M.D., Johanna Melo-Cardenas, B.Sc, Jose Sandoval-Sus, Mauricio Urquiza, Charles Prussak, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 376.
https://doi.org/10.1182/blood.V114.22.376.376
Published: 2009
Journal Articles

A Phase I Study of Immune Gene Therapy for Patients with CLL Using Intranodal Injection of ISF35, a Membrane-Stable CD40 Binding Protein.

Januario Castro, MD, Jose D. Sandoval, MD, Johanna Melo-Cardenas, B.Sc, Denise Darrah, RN, Mauricio Urquiza, PhD, Charles Prussak, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2100.
https://doi.org/10.1182/blood.V112.11.2100.2100
Published: 2008